206 related articles for article (PubMed ID: 18436649)
21. Novel protective mechanism against irreversible hyperoxidation of peroxiredoxin: Nalpha-terminal acetylation of human peroxiredoxin II.
Seo JH; Lim JC; Lee DY; Kim KS; Piszczek G; Nam HW; Kim YS; Ahn T; Yun CH; Kim K; Chock PB; Chae HZ
J Biol Chem; 2009 May; 284(20):13455-13465. PubMed ID: 19286652
[TBL] [Abstract][Full Text] [Related]
22. Insights into the catalytic mechanism of the Bcp family: functional and structural analysis of Bcp1 from Sulfolobus solfataricus.
D'Ambrosio K; Limauro D; Pedone E; Galdi I; Pedone C; Bartolucci S; De Simone G
Proteins; 2009 Sep; 76(4):995-1006. PubMed ID: 19338062
[TBL] [Abstract][Full Text] [Related]
23. Identification of intact protein thiosulfinate intermediate in the reduction of cysteine sulfinic acid in peroxiredoxin by human sulfiredoxin.
Jönsson TJ; Tsang AW; Lowther WT; Furdui CM
J Biol Chem; 2008 Aug; 283(34):22890-4. PubMed ID: 18593714
[TBL] [Abstract][Full Text] [Related]
24. Catalytic mechanism of thiol peroxidase from Escherichia coli. Sulfenic acid formation and overoxidation of essential CYS61.
Baker LM; Poole LB
J Biol Chem; 2003 Mar; 278(11):9203-11. PubMed ID: 12514184
[TBL] [Abstract][Full Text] [Related]
25. Protein engineering of the quaternary sulfiredoxin.peroxiredoxin enzyme.substrate complex reveals the molecular basis for cysteine sulfinic acid phosphorylation.
Jönsson TJ; Johnson LC; Lowther WT
J Biol Chem; 2009 Nov; 284(48):33305-10. PubMed ID: 19812042
[TBL] [Abstract][Full Text] [Related]
26. Multiscale Modeling of Thiol Overoxidation in Peroxiredoxins by Hydrogen Peroxide.
Semelak JA; Battistini F; Radi R; Trujillo M; Zeida A; Estrin DA
J Chem Inf Model; 2020 Feb; 60(2):843-853. PubMed ID: 31718175
[TBL] [Abstract][Full Text] [Related]
27. Crystal structure of reduced and of oxidized peroxiredoxin IV enzyme reveals a stable oxidized decamer and a non-disulfide-bonded intermediate in the catalytic cycle.
Cao Z; Tavender TJ; Roszak AW; Cogdell RJ; Bulleid NJ
J Biol Chem; 2011 Dec; 286(49):42257-42266. PubMed ID: 21994946
[TBL] [Abstract][Full Text] [Related]
28. The crystal structures of oxidized forms of human peroxiredoxin 5 with an intramolecular disulfide bond confirm the proposed enzymatic mechanism for atypical 2-Cys peroxiredoxins.
Smeets A; Marchand C; Linard D; Knoops B; Declercq JP
Arch Biochem Biophys; 2008 Sep; 477(1):98-104. PubMed ID: 18489898
[TBL] [Abstract][Full Text] [Related]
29. Reduction of sulfenic acids by ascorbate in proteins, connecting thiol-dependent to alternative redox pathways.
Anschau V; Ferrer-Sueta G; Aleixo-Silva RL; Bannitz Fernandes R; Tairum CA; Tonoli CCC; Murakami MT; de Oliveira MA; Netto LES
Free Radic Biol Med; 2020 Aug; 156():207-216. PubMed ID: 32615144
[TBL] [Abstract][Full Text] [Related]
30. Sulfiredoxin, the cysteine sulfinic acid reductase specific to 2-Cys peroxiredoxin: its discovery, mechanism of action, and biological significance.
Rhee SG; Jeong W; Chang TS; Woo HA
Kidney Int Suppl; 2007 Aug; (106):S3-8. PubMed ID: 17653208
[TBL] [Abstract][Full Text] [Related]
31. The mycobacterial thioredoxin peroxidase can act as a one-cysteine peroxiredoxin.
Trujillo M; Mauri P; Benazzi L; Comini M; De Palma A; Flohé L; Radi R; Stehr M; Singh M; Ursini F; Jaeger T
J Biol Chem; 2006 Jul; 281(29):20555-66. PubMed ID: 16682410
[TBL] [Abstract][Full Text] [Related]
32. Alteration of molecular assembly of peroxiredoxins from hyperthermophilic archaea.
Nakamura T; Oshima M; Yasuda M; Shimamura A; Morita J; Uegaki K
J Biochem; 2017 Dec; 162(6):415-422. PubMed ID: 28992240
[TBL] [Abstract][Full Text] [Related]
33. Evidence for the formation of a covalent thiosulfinate intermediate with peroxiredoxin in the catalytic mechanism of sulfiredoxin.
Roussel X; Béchade G; Kriznik A; Van Dorsselaer A; Sanglier-Cianferani S; Branlant G; Rahuel-Clermont S
J Biol Chem; 2008 Aug; 283(33):22371-82. PubMed ID: 18552404
[TBL] [Abstract][Full Text] [Related]
34. Inactivation of human peroxiredoxin I during catalysis as the result of the oxidation of the catalytic site cysteine to cysteine-sulfinic acid.
Yang KS; Kang SW; Woo HA; Hwang SC; Chae HZ; Kim K; Rhee SG
J Biol Chem; 2002 Oct; 277(41):38029-36. PubMed ID: 12161445
[TBL] [Abstract][Full Text] [Related]
35. The catalytic mechanism of peroxiredoxins.
Poole LB
Subcell Biochem; 2007; 44():61-81. PubMed ID: 18084890
[TBL] [Abstract][Full Text] [Related]
36. Dissecting peroxiredoxin catalysis: separating binding, peroxidation, and resolution for a bacterial AhpC.
Parsonage D; Nelson KJ; Ferrer-Sueta G; Alley S; Karplus PA; Furdui CM; Poole LB
Biochemistry; 2015 Feb; 54(7):1567-75. PubMed ID: 25633283
[TBL] [Abstract][Full Text] [Related]
37. Characterization of a mammalian peroxiredoxin that contains one conserved cysteine.
Kang SW; Baines IC; Rhee SG
J Biol Chem; 1998 Mar; 273(11):6303-11. PubMed ID: 9497358
[TBL] [Abstract][Full Text] [Related]
38. Cysteine pK(a) values for the bacterial peroxiredoxin AhpC.
Nelson KJ; Parsonage D; Hall A; Karplus PA; Poole LB
Biochemistry; 2008 Dec; 47(48):12860-8. PubMed ID: 18986167
[TBL] [Abstract][Full Text] [Related]
39. Differential parameters between cytosolic 2-Cys peroxiredoxins, PRDX1 and PRDX2.
Dalla Rizza J; Randall LM; Santos J; Ferrer-Sueta G; Denicola A
Protein Sci; 2019 Jan; 28(1):191-201. PubMed ID: 30284335
[TBL] [Abstract][Full Text] [Related]
40. Oxidation of active center cysteine of bovine 1-Cys peroxiredoxin to the cysteine sulfenic acid form by peroxide and peroxynitrite.
Peshenko IV; Shichi H
Free Radic Biol Med; 2001 Aug; 31(3):292-303. PubMed ID: 11461766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
